Pasquale Giordano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pasquale Giordano has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Anna Skay
2 shared publicationsIvan Tomasi
2 shared publications- Shelly C. Lu
Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
2 shared publications A. Pascariello
Department of Colorectal Surgery Barts Health London UK
1 shared publicationA. Stuto
General Surgery Department, Ospedale Santa Maria degli Angeli, Pordenone, Italy
1 shared publicationB. Griffiths
NUTH Foundation Trust, Newcastle, UK
1 shared publication
Latest Publications
- 3 March 2016
- Published by Wiley in Colorectal Disease
- Vol. 18 (3) , 286-294
A prospective multicentre observational study of Permacol™ collagen paste for anorectal fistula: preliminary results
Aim: Permacol™ collagen paste (Permacol paste) is a new option for the treatment of anorectal fistula. It functions by filling the fistula tract with an acellular crosslinked porcine dermal collagen matrix suspension. The MASERATI 100 study group was set up to evaluate the clinical outcome of Permacol paste in the treatment of anorectal fistula. This paper reports the results from the initial 30 patients enrolled in the MASERATI 100 prospective, observational clinical trial.Method: Patients (N = 30) with anal fistula presenting to 10 European academic surgical units were treated with a sphincter‐preserving technique using Permacol paste. Fistula healing was assessed at 1, 3, 6 and 12 months after treatment, with the primary end‐point of fistula healing at 6 months post‐surgery. Faecal continence and patient satisfaction were recorded at each follow‐up visit and adverse events were monitored throughout the follow‐up.Results: Of the 28 patients with data at 6 months post‐surgery, 15 (54%) were healed, and the healing rate was maintained at 12 months. Healing after treatment with Permacol paste was similar for intersphincteric to transsphincteric fistulae and primary or recurrent fistulae. Only one patient exhibited an adverse event (perianal abscess) that was possibly related to the treatment. At the last outpatient visit, over 60% of patients were satisfied or very satisfied with the operation.Conclusion: Permacol paste is shown to be effective in treating primary and recurrent cryptoglandular anorectal fistula with minimal unwanted side effects.
- 3 March 2016
- Published by Wiley in Colorectal Disease
- Vol. 18 (3) , 286-294
A prospective multicentre observational study of Permacol™ collagen paste for anorectal fistula: preliminary results
Aim: Permacol™ collagen paste (Permacol paste) is a new option for the treatment of anorectal fistula. It functions by filling the fistula tract with an acellular crosslinked porcine dermal collagen matrix suspension. The MASERATI 100 study group was set up to evaluate the clinical outcome of Permacol paste in the treatment of anorectal fistula. This paper reports the results from the initial 30 patients enrolled in the MASERATI 100 prospective, observational clinical trial.Method: Patients (N = 30) with anal fistula presenting to 10 European academic surgical units were treated with a sphincter‐preserving technique using Permacol paste. Fistula healing was assessed at 1, 3, 6 and 12 months after treatment, with the primary end‐point of fistula healing at 6 months post‐surgery. Faecal continence and patient satisfaction were recorded at each follow‐up visit and adverse events were monitored throughout the follow‐up.Results: Of the 28 patients with data at 6 months post‐surgery, 15 (54%) were healed, and the healing rate was maintained at 12 months. Healing after treatment with Permacol paste was similar for intersphincteric to transsphincteric fistulae and primary or recurrent fistulae. Only one patient exhibited an adverse event (perianal abscess) that was possibly related to the treatment. At the last outpatient visit, over 60% of patients were satisfied or very satisfied with the operation.Conclusion: Permacol paste is shown to be effective in treating primary and recurrent cryptoglandular anorectal fistula with minimal unwanted side effects.
- Open Access
- 12 April 2014
- Published by Wiley in Colorectal Disease
- Vol. 16 (5) , 373-376
Transanal dearterialization with targeted mucopexy is effective for advanced haemorrhoids
Aim: Transanal haemorrhoidal dearterialization (THD) has become well established for the treatment of haemorrhoids. In this study we describe a technical modification of this technique, targeted mucopexy (THD TM), and report the results for advanced haemorrhoids.Method: The study included a prospective evaluation of patients with Grade IV (fourth‐degree) haemorrhoids operated on with the THD TM technique. This consisted of an initial dearterialization when the haemorrhoidal arteries were transfixed and a second phase of mucopexy, using a different needle from that usually used in the original technique.Results: From January 2007 to December 2011, 31 consecutive patients with Grade IV haemorrhoids were operated on using the THD TM technique. Postoperative pain was reported by 22 (70%) patients on day 1 and 19 (61%) on day 7, while nine (30%) did not experience any pain at all. Severe pain was reported by only nine (16%) patients. At a mean follow‐up of 32 months, two (6.4%) patients required a further intervention for on‐going symptoms.Conclusion: Transanal haemorrhoidal dearterialization TM is effective for advanced haemorrhoids.
- 12 April 2014
- Published by Wiley in Colorectal Disease
- Vol. 16 (5) , 373-376
Open AccessTransanal dearterialization with targeted mucopexy is effective for advanced haemorrhoids
Aim: Transanal haemorrhoidal dearterialization (THD) has become well established for the treatment of haemorrhoids. In this study we describe a technical modification of this technique, targeted mucopexy (THD TM), and report the results for advanced haemorrhoids.Method: The study included a prospective evaluation of patients with Grade IV (fourth‐degree) haemorrhoids operated on with the THD TM technique. This consisted of an initial dearterialization when the haemorrhoidal arteries were transfixed and a second phase of mucopexy, using a different needle from that usually used in the original technique.Results: From January 2007 to December 2011, 31 consecutive patients with Grade IV haemorrhoids were operated on using the THD TM technique. Postoperative pain was reported by 22 (70%) patients on day 1 and 19 (61%) on day 7, while nine (30%) did not experience any pain at all. Severe pain was reported by only nine (16%) patients. At a mean follow‐up of 32 months, two (6.4%) patients required a further intervention for on‐going symptoms.Conclusion: Transanal haemorrhoidal dearterialization TM is effective for advanced haemorrhoids.
- 1 January 2014
- Published by Springer Nature
- p. 167-172
The Express Procedure for Internal Rectal Prolapse
- 1 January 2014
- Published by Springer Nature
- p. 167-172
The Express Procedure for Internal Rectal Prolapse
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1688 Polyamine and Methionine Adenosyltransferase 2A Crosstalk in Human Colon Cancer
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1688 Polyamine and Methionine Adenosyltransferase 2A Crosstalk in Human Colon Cancer
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
607 Ubiquitin-Conjugating Enzyme 9-Methionine Adenosyltransferase 2A-Bcl2 Axis Regulates Apoptosis in Liver and Colon Cancer Cells
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
607 Ubiquitin-Conjugating Enzyme 9-Methionine Adenosyltransferase 2A-Bcl2 Axis Regulates Apoptosis in Liver and Colon Cancer Cells